Characterization of osseointegrative phosphatidylserine and cholesterol orthopaedic implant coatings
Total joint arthroplasties/replacements are one of the most successful surgeries available today for improving patients’ quality of life. By 2030 in the US, demand for primary total hip and knee arthroplasties are expected to grow by 174% and 673% respectively to a combined total of over 4 million procedures performed annually, driven largely by an ageing population and an increased occurrence of obesity. Current patient options for load-bearing bone integrating implants have significant shortcomings. Nearly a third of patients require a revision surgery before the implant is 15 years old, and ...
(For more, see "View full record.")